Endoscopic detection of proximal serrated lesions and pathologic identification of sessile serrated adenomas/polyps vary on the basis of center

Clinical Gastroenterology and Hepatology

Volumn 12, Issue 7, 2014, Pages 1119-1126

  Payne, Shannon R ^a   Church, Timothy R ^b   Wandell, Michael ^c   Rösch, Thomas ^d   Osborn, Neal ^e   Snover, Dale ^f   Day, Robert W ^g,h   Ransohoff, David F ⁱ   Rex, Douglas K ^j  

^a University of Minnesota School of Public Health ^*

^b UNIVERSITY OF MINNESOTA   (United States)

^c CRQ Insight LLC   (United States)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^e Atlanta Gastroenterology Associates   (United States)

^f FAIRVIEW SOUTHDALE HOSPITAL   (United States)

^g Fred Hutchinson Cancer Research Center   (United States)

^h EPIGENOMICS AG   (Germany)

ⁱ UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^j INDIANA UNIVERSITY   (United States)

more..

Author keywords

Cancer screening; Colon cancer; Early detection; Hyperplastic polyp; Sessile serrated adenoma; Sessile serrated polyp

Indexed keywords

ADULT; AGED; ARTICLE; COLONOSCOPY; FEMALE; GASTROENTEROLOGIST; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PROSPECTIVE STUDY; RECTUM ADENOMA;

EID: 84902544615     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2013.11.034     Document Type: Article

References (24)

1. Leggett B., Whitehall V. Role of the serrated pathway in colorectal cancer pathogenesis. Gastroenterology 2010, 138:2088-2100.
2. Ogino S., Stampfer M. Lifestyle factors and microsatellite instability in colorectal cancer: the evolving field of molecular pathological epidemiology. JNatl Cancer Inst 2010, 102:365-367.
3. Toyota M., Ahuja N., Ohe-Toyota M., et al. CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A 1999, 96:8681-8686.
4. Samowitz W.S., Albertsen H., Herrick J., et al. Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer. Gastroenterology 2005, 129:837-845.
5. Hawkins N., Norrie M., Cheong K., et al. CpG island methylation in sporadic colorectal cancers and its relationship to microsatellite instability. Gastroenterology 2002, 122:1376-1387.
6. Ogino S., Nosho K., Kirkner G.J., et al. CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer. Gut 2009, 58:90-96.
7. Nosho K., Yamamoto H., Takamaru H., et al. Acase of colorectal carcinoma in adenoma analyzed by a cDNA array. Int J Colorectal Dis 2005, 20:287-291.
8. Nagasaka T., Koi M., Kloor M., et al. Mutations in both KRAS and BRAF may contribute to the methylator phenotype in colon cancer. Gastroenterology 2008, 134:1950-1960.
9. Rajagopalan H., Bardelli A., Lengauer C., et al. Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status. Nature 2002, 418:934.
10. Kambara T., Simms L.A., Whitehall V.L., et al. BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum. Gut 2004, 53:1137-1144.
11. Weisenberger D.J., Siegmund K.D., Campan M., et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet 2006, 38:787-793.
12. Chan T.L., Zhao W., Leung S.Y., et al. BRAF and KRAS mutations in colorectal hyperplastic polyps and serrated adenomas. Cancer Res 2003, 63:4878-4881.
13. Jass J.R., Iino H., Ruszkiewicz A., et al. Neoplastic progression occurs through mutator pathways in hyperplastic polyposis of the colorectum. Gut 2000, 47:43-49.
14. Park S.J., Rashid A., Lee J.H., et al. Frequent CpG island methylation in serrated adenomas of the colorectum. Am J Pathol 2003, 162:815-822.
15. Tadepalli U.S., Feihel D., Miller K.M., et al. Amorphologic analysis of sessile serrated polyps observed during routine colonoscopy (with video). Gastrointest Endosc 2011, 74:1360-1368.
16. Pabby A., Schoen R.E., Weissfeld J.L., et al. Analysis of colorectal cancer occurrence during surveillance colonoscopy in the Dietary Polyp Prevention Trial. Gastrointest Endosc 2005, 61:385-391.
17. Rex D.K., Ahnen D.J., Baron J.A., et al. Serrated lesions of the colorectum: review and recommendations from an expert panel. Am J Gastroenterol 2012, 107:1315-1329.
18. Hetzel J., Huang C.S., Coukos J.A., et al. Variation in the detection of serrated polyps in an average risk colorectal cancer screening cohort. Am J Gastroenterol 2010, 105:2656-2664.
19. Kahi C.J., Hewett D.G., Norton D.L., et al. Prevalence and variable detection of proximal colon serrated polyps during screening colonoscopy. Clin Gastroenterol Hepatol 2011, 9:42-46.
20. Church T.R., Wandell M., Lofton-Day C., et al. Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer. Gut 2014, 63:317-325.
21. Khalid O., Radaideh S., Cummings O.W., et al. Reinterpretation of histology of proximal colon polyps called hyperplastic in 2001. World J Gastroenterol 2009, 15:3767-3770.
22. Glatz K., Pritt B., Glatz D., et al. Amultinational, internet-based assessment of observer variability in the diagnosis of serrated colorectal polyps. Am J Clin Pathol 2007, 127:938-945.
23. Sandmeier D., Seelentag W., Bouzourene H. Serrated polyps of the colorectum: is sessile serrated adenoma distinguishable from hyperplastic polyp in a daily practice?. Virchows Arch 2007, 450:613-618.
24. Lieberman D.A., Rex D.K., Winawer S.J., et al. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology 2012, 143:844-857.